{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:04:48Z","timestamp":1789538688327,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gastric cancer is a major malignancy with molecular heterogeneity and limited biomarkers for risk stratification and therapeutic guidance. Interferon-stimulated 20 kDa exonuclease-like 2 (ISG20L2), a regulator of ribosome biogenesis, has been implicated in tumor progression, but its relevance in gastric cancer is poorly defined. This study aimed to characterize the potential pro-oncogenic and immune relevance of ISG20L2 in gastric cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Public multi-omics datasets and two single-cell RNA-sequencing cohorts were used to evaluate ISG20L2 expression and its associations with molecular features, tumor functional states, immune infiltration, and immunotherapy-related characteristics. Protein expression was validated in gastric cancer cell lines and nine paired clinical tissues, and functional effects of ISG20L2 knockdown were assessed in AGS and HGC-27 cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ISG20L2 was significantly upregulated in gastric cancer and inversely correlated with promoter methylation. Single-cell analysis showed predominant enrichment of ISG20L2 in exhausted CD8+ T cells. High ISG20L2 expression was closely associated with cell-cycle activity, immune infiltration, PD-L1 expression and predicted immunotherapy response. Experimentally, ISG20L2 protein was elevated in gastric cancer cell lines and tumor tissues. ISG20L2 knockdown markedly suppressed proliferation, clonogenicity, migration and invasion in both AGS and HGC-27 cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ISG20L2 is aberrantly upregulated and associated with malignant biological features and immune-related characteristics in gastric cancer, supporting its potential role as a pro-oncogenic regulator and a candidate molecular indicator requiring further clinical validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1906513","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:31:57Z","timestamp":1789536717000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics and experimental validation reveal ISG20L2 as a potential pro-oncogenic regulator in gastric cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Song","family":"Liang","sequence":"first","affiliation":[{"name":"Department of General Surgery, Lu\u2019an Affiliated Hospital of Anhui Medical University","place":["Lu\u2019an, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lu\u2019an Affiliated Hospital of Anhui Medical University","place":["Lu\u2019an, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lu\u2019an Affiliated Hospital of Anhui Medical University","place":["Lu\u2019an, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuansi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lu\u2019an Affiliated Hospital of Anhui Medical University","place":["Lu\u2019an, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuming","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lu\u2019an Affiliated Hospital of Anhui Medical University","place":["Lu\u2019an, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenwei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Lu\u2019an Affiliated Hospital of Anhui Medical University","place":["Lu\u2019an, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"He","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Thyroid Surgery, Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16172948","article-title":"Epidemiology of gastric cancer-changing trends and global disparities","volume":"16","author":"Inoue","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s014\\0-6736(25)00052-2","article-title":"Gastric cancer","volume":"405","author":"Sundar","year":"2025","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.103038","article-title":"Precision oncology in gastric cancer: Shaping the future of personalized treatment","volume":"141","author":"Migliore","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5230\/jgc.2026.26.e12","article-title":"Evolving molecular subtypes of gastric cancer: From past classifications to present consensus and future directions for precision therapy","volume":"26","author":"Lee","year":"2026","journal-title":"J Gastric Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2025.05.007","article-title":"Gastric cancer: From biomarkers to functional precision medicine","volume":"31","author":"Albrecht","year":"2025","journal-title":"Trends Mol Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-025-03865-6","article-title":"Biomarkers in gastroesophageal cancer 2025: An updated consensus statement by the Spanish Society of Medical Oncology (Seom) and the Spanish Society of Pathology (Seap)","volume":"27","author":"Alsina Maqueda","year":"2025","journal-title":"Clin Transl Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-024-02084-x","article-title":"The role of micrornas in the gastric cancer tumor microenvironment","volume":"23","author":"Yu","year":"2024","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2025.149871","article-title":"Core role of H19 lncrna in gastric cancer: From tumor ecosystem reprogramming to precision therapy","volume":"976","author":"Zeng","year":"2026","journal-title":"Gene"},{"key":"B10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/17474124.2020.1715211","article-title":"Functions of circular rnas and their potential applications in gastric cancer","volume":"14","author":"Ruan","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6236","article-title":"Kcnd2: A prognostic biomarker and regulator of immune function in gastric cancer","volume":"12","author":"Zhou","year":"2023","journal-title":"Cancer Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i33.9707","article-title":"Contactin 1: A potential therapeutic target and biomarker in gastric cancer","volume":"21","author":"Chen","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2025.117536","article-title":"Catalytic hairpin assembly-powered nanozyme-sers dual-function sensing system for ultrasensitive detection of gastric precancerous lesions","volume":"283","author":"Zhuang","year":"2025","journal-title":"Biosens Bioelectron"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1310258","article-title":"An aptamer and Au\/Si cca based sers sensor for ultra-sensitive detection of vimentin during emt in gastric cancer","volume":"11","author":"Cheng","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16660","article-title":"Study of mirna and lymphocyte subsets as potential biomarkers for the diagnosis and prognosis of gastric cancer","volume":"12","author":"Li","year":"2024","journal-title":"PeerJ"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf1180","article-title":"The 3\u2032\u20135\u2032 exoribonuclease isg20l2 contributes to 3\u2032 terminus maturation of 18s and 28s ribosomal rnas","volume":"53","author":"Aubert","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1210","article-title":"Molecular mechanism of human isg20l2 for the its1 cleavage in the processing of 18s precursor ribosomal rna","volume":"52","author":"Ma","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-2025-1546","article-title":"Isg20l2 as a driver in the proliferation and invasion of lung adenocarcinoma via nkx2-1 regulation","volume":"14","author":"Fang","year":"2025","journal-title":"Trans Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"15610","DOI":"10.1038\/s41598-021-95068-6","article-title":"Cenpl, isg20l2, lsm4, mrpl3 are four novel hub genes and may serve as diagnostic and prognostic markers in breast cancer","volume":"11","author":"Yin","year":"2021","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30015","article-title":"A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis","volume":"236","author":"Xiao","year":"2021","journal-title":"J Cell Physiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00018-023-04925-2","article-title":"Isg20l2: An rna nuclease regulating T cell activation","volume":"80","author":"Rodr\u00edguez-Gal\u00e1n","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M700510-MCP200","article-title":"Isg20l2, a novel vertebrate nucleolar exoribonuclease involved in ribosome biogenesis*","volume":"7","author":"Cout\u00e9","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/biom8040123","article-title":"Pre-ribosomal rna processing in human cells: From mechanisms to congenital diseases","volume":"8","author":"Aubert","year":"2018","journal-title":"Biomolecules"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.cell.2024.01.043","article-title":"Snapshot: Eukaryotic ribosome biogenesis ii","volume":"187","author":"Hurt","year":"2024","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-022-01285-4","article-title":"Ribosome biogenesis in disease: New players and therapeutic targets","volume":"8","author":"Jiao","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2022.03.043","article-title":"The homeostatic regulation of ribosome biogenesis","volume":"136","author":"Ni","year":"2023","journal-title":"Semin Cell Dev Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcae017","article-title":"The impact of ribosome biogenesis in cancer: From proliferation to metastasis","volume":"6","author":"Hwang","year":"2024","journal-title":"NAR Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae023","article-title":"Genomic hallmarks and therapeutic targets of ribosome biogenesis in cancer","volume":"25","author":"Zang","year":"2024","journal-title":"Brief Bioinform"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152534","article-title":"Ribosome biogenesis and function in cancer: From mechanisms to therapy","volume":"17","author":"Gitareja","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157081","article-title":"Isg20l2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to psmb5","volume":"7","author":"Yang","year":"2022","journal-title":"JCI Insight"},{"key":"B31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13046-024-02960-w","article-title":"T-cell infiltration and its regulatory mechanisms in cancers: Insights at single-cell resolution","volume":"43","author":"Yang","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of pd-1\/pd-l1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1476904","article-title":"Cd8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: Key to the success of immunotherapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1906513\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:31:58Z","timestamp":1789536718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1906513\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":33,"alternative-id":["10.3389\/fonc.2026.1906513"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1906513","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1906513"}}